Home/Filings/4/0001179110-17-005299
4//SEC Filing

INVIVO THERAPEUTICS HOLDINGS CORP. 4

Accession 0001179110-17-005299

CIK 0001292519operating

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 3:09 PM ET

Size

5.5 KB

Accession

0001179110-17-005299

Insider Transaction Report

Form 4
Period: 2017-03-29
McNulty Christopher
Chief Financial Officer
Transactions
  • Award

    Employee stock option (right to buy)

    2017-03-29+29,97329,973 total
    Exercise: $4.00Exp: 2027-03-29Common Stock (29,973 underlying)
Footnotes (1)
  • [F1]This option vests as to 25% of the shares on March 29, 2018, and the remaining shares vest thereafter on a monthly basis in 36 equal monthly installments.

Issuer

INVIVO THERAPEUTICS HOLDINGS CORP.

CIK 0001292519

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001292519

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 3:09 PM ET
Size
5.5 KB